Stomach disease
Conditions
Interventions
A Group:The patients were given different concentrations of terbinafine intravenously and then 0.2 mg/kg of remazolam intravenously. The blood oxygen saturation, heart rate, blood pressure and visual
B Group:Remifentanil Remimazolam
Sponsors
Chizhou People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.ASA I or II; 2. Age 18-65; 3. BMI 18.5-24.9 4. Patients who are going to undergo painless gastroscopy; 5. Patients or authorized persons sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Allergy or contraindications to the anesthetic regimen; 2. Upper gastrointestinal bleeding or significant coagulation disorders, severe organ dysfunction, or critical cardiovascular/cerebrovascular conditions; 3. Potential airway obstruction; 4. History of long-term psychiatric medication use or cognitive impairment that prevents cooperation; 5. Alcoholism or drug addiction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood oxygen saturation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure;Heart Rate;Visual Simulation Pain Rating; | — |
Countries
China
Contacts
Public ContactMingsheng Bao
Chizhou People's Hospital
Outcome results
None listed